Picture of Multiqure SA logo

MQR — Multiqure SA News Story

0.000.00%
pl flag iconLast trade - 00:00
IndustrialsHighly SpeculativeSmall CapSucker Stock

Brief: Pure Biologics Signs Deal With Timeline Bioresearch For Pre-Clinical Trial Under PB001 Project

Nov 19 (Reuters) - Pure Biologics SA  PUR1.WA :
    * SIGNS DEAL WITH SWEDEN-BASED TIMELINE BIORESEARCH AB FOR
CARRYING OUT PRE-CLINICAL TRIAL UNDER PB001 PROJECT
    * PB001 PROJECT REGARDS ONCOLOGICAL IMMUNOTHERAPY

Source text for Eikon:  ID:nEM4GKpnMa 
Further company coverage:  PUR1.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Multiqure SA

See all news